 |
| 27-Jul-12 | Downgrade |
Canaccord Genuity |
Buy → Hold |
|
|
| 25-Apr-11 | Upgrade |
Wedbush |
Underperform → Neutral |
$18 → $22 |
|
| 24-Mar-11 | Upgrade |
Canaccord Genuity |
Hold → Buy |
$30 |
|
| 16-Nov-10 | Initiated |
Canaccord Genuity |
Hold |
$21 |
|
| 07-Apr-10 | Initiated |
Wedbush |
Underperform |
$18 |
|
| 13-Nov-09 | Reiterated |
Caris & Company |
Average |
$21 → $20 |
|
| 07-Jul-09 | Initiated |
Caris & Company |
Average |
$21 |
|
| 06-Mar-09 | Initiated |
William Blair |
Mkt Perform |
|
|
| 14-Oct-08 | Initiated |
Lazard Capital |
Buy |
$30 |
|
| 21-Jul-08 | Upgrade |
Hilliard Lyons |
Neutral → Long-term Buy |
|
|
| 14-May-08 | Initiated |
Susquehanna Financial |
Neutral |
|
|
| 13-May-08 | Initiated |
CL King |
Accumulate |
|
|
| 16-Apr-07 | Downgrade |
Hilliard Lyons |
Long-term Buy → Neutral |
|
|
| 22-Jan-07 | Reiterated |
Hilliard Lyons |
Long-term Buy |
$30 → $32 |
|
|
|
| 10-Jun-13 10:30AM | InPlay: Meridian Bioscience receives FDA clearance for new molecular amplification test: illumigene Mycoplasma Briefing.com |
| 10:30AM | Meridian Bioscience Receives FDA Clearance for New Molecular Amplification Test: illumigene® Mycoplasma Business Wire |
| 04-Jun-13 05:23PM | 3 High Dividend Healthcare Stocks at Motley Fool |
| 20-May-13 03:09PM | VIVO January 2014 Options Begin Trading at Forbes |
| 17-May-13 01:04PM | MERIDIAN BIOSCIENCE INC Financials EDGAR Online Financials |
| 10-May-13 02:29AM | MERIDIAN BIOSCIENCE INC Files SEC form 10-Q, Quarterly Report EDGAR Online |
| 06-May-13 10:37AM | 9 Top Healthcare Dogs Hunt 3.5% To 51.9% Gains In April at Seeking Alpha |
| 10:09AM | This ETF Holds Stocks Insiders Want to Own at Forbes |
| 03-May-13 01:35PM | Friday 5/3 Insider Buying Report: HTCH, VIVO at Forbes |
| 30-Apr-13 11:24AM | Meridian Bioscience About To Put More Money In Your Pocket at Forbes |
| 29-Apr-13 01:03PM | Meridian Bioscience Named Top Dividend Stock With Insider Buying and 3.88% Yield at Forbes |
| 28-Apr-13 12:22PM | 1 Winner and 4 Losers from This Weeks Earnings Storm at Wall St. Cheat Sheet |
| 26-Apr-13 11:45AM | Top Ranked Dividend Stock VIVO Enters Oversold Territory at TheStreet |
| 11:15AM | Notable Two Hundred Day Moving Average Cross - VIVO at Forbes |
| 03:57AM | MERIDIAN BIOSCIENCE INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and E EDGAR Online |
| 25-Apr-13 01:07PM | Meridian Bioscience Earnings: Heres Why Investors Dont Like These Results at Wall St. Cheat Sheet -5.64% |
| 07:26AM | InPlay: Meridian Bioscience reports EPS in-line, misses on revs; reaffirms FY13 EPS guidance, revs guidance Briefing.com |
| 07:15AM | Meridian Bioscience Reports Second Quarter and Six Months Operating Results, Declares Regular Cash Dividend, and Reaffirms Fiscal 2013 Guidance Business Wire |
| 07:07AM | Q2 2013 Meridian Bioscience, Inc. Earnings Release - Before Market Open CCBN |
| 17-Apr-13 07:22AM | Money Managers Are Buying 5 Dividend Stocks With A Higher ROI Than Industry Peers at Seeking Alpha |
| 12-Apr-13 09:23AM | Meridian Bioscience initiated with a Buy at Sidoti at theflyonthewall.com |
| 28-Mar-13 11:00AM | Meridian Bioscience Recognized by Forbes as One of Americas 100 Most Trustworthy Companies Business Wire |
| 19-Mar-13 08:30AM | TravelCenters Of America Profits Rise and 3 Stocks At 52-Week Highs at Wall St. Cheat Sheet |
| 18-Mar-13 12:48PM | InPlay: Meridian Bioscience announces illumigene Group A Streptococcus and illumigene Group B Streptococcus tests categorized 'moderate complexity' by FDA Briefing.com |
| 11:45AM | Meridian Bioscience Announces illumigene® Group A Streptococcus and illumigene® Group B Streptococcus Tests Categorized Moderate Complexity by FDA Business Wire |
| 15-Mar-13 11:00AM | Wall Street Transcript Interview with Steven Quay, CEO of Atossa Genetics, Inc. (ATOS) Wall Street Transcript |
| 08-Mar-13 02:56AM | Money Managers Are Buying These 5 Dividend Stocks With Higher ROI Than Industry Peers at Seeking Alpha |
| 25-Feb-13 01:34AM | A Hidden Reason Meridian Bioscience's Future Looks Bright at Motley Fool |
| 14-Feb-13 01:04PM | MERIDIAN BIOSCIENCE INC Financials EDGAR Online Financials |
| 12-Feb-13 10:30AM | Meridian Bioscience Tests Well, Pays Healthy Dividends at Forbes |
| 11-Feb-13 04:05PM | Mayersons Stir Crazy, FlatTop Grill parent files for bankruptcy at bizjournals.com |
| 09:51AM | MERIDIAN BIOSCIENCE INC Files SEC form 10-Q, Quarterly Report EDGAR Online |
| 06-Feb-13 07:00AM | Bioline Launches ISOLATE II, a Precious Find for DNA and RNA Isolation Business Wire |
| 30-Jan-13 09:45AM | BMRA: Initiating at Outperform Zacks Small Cap Research |
| 24-Jan-13 04:17PM | Meridian Bioscience Beats on Both Top and Bottom Lines at Motley Fool |
| 03:59PM | Meridian 1Q sales jump 13% at bizjournals.com |
| 02:57PM | Hillenbrand, Meridian, CECO top Couriers 2013 stock contest picks at bizjournals.com |
| 02:53PM | What to Expect from Meridian Bioscience at Motley Fool |
| 02:50PM | MERIDIAN BIOSCIENCE INC Files SEC form 8-K, Results of Operations and Financial Condition, Submission of Matters to a EDGAR Online |
| 23-Jan-13 11:48AM | Meridian posts greater 1Q income, but shares slip AP -5.08% |
| 10:06AM | Why Meridian Bioscience Is Poised to Outperform at Motley Fool |
| 07:34AM | InPlay: Meridian Bioscience beats by $0.01, beats on revs; reaffirms FY13 EPS guidance, revs guidance Briefing.com |
| 07:33AM | Meridian Bioscience reaffirms FY13 guidance at theflyonthewall.com |
| 07:30AM | Meridian Bioscience Reports First Quarter 2013 Operating Results and Reaffirms Fiscal 2013 Guidance Business Wire |
| 03:40AM | What Does Wall Street See for Meridian Bioscience's Q1? at Motley Fool |
| 07-Jan-13 02:39PM | Bottom 10 Cincinnati stocks of 2012: SLIDESHOW at bizjournals.com |
| 04-Jan-13 09:13AM | This Metric Says You're Smart to Own Meridian Bioscience at Motley Fool |
| 26-Dec-12 06:04PM | Has Neogen Become the Perfect Stock? at Motley Fool |
| 17-Dec-12 09:42AM | Abercrombie & Fitch Risk/Reward Deemed Attractive and 4 Stock Analyses Turning Heads at Wall St. Cheat Sheet |
| 14-Dec-12 04:49PM | Meridien Completes Beta Trials Zacks |
| 02:19PM | VIVO Crosses Below Key Moving Average Level at Forbes |
| 13-Dec-12 06:46PM | InPlay from Briefing.com Briefing.com |
| 06:31PM | InPlay from Briefing.com Briefing.com |
| 06:07PM | InPlay from Briefing.com Briefing.com |
| 06:01PM | Meridian Bioscience Named Top Dividend Stock With Insider Buying and 3.77% Yield at Forbes |
| 05:31PM | InPlay from Briefing.com Briefing.com |
| 04:57PM | InPlay from Briefing.com Briefing.com |
| 04:21PM | InPlay from Briefing.com Briefing.com |
| 03:45PM | InPlay from Briefing.com Briefing.com |
| 02:46PM | InPlay: Meridian Bioscience has successfully completed beta trials for two new illumigene molecular amplification tests Briefing.com |
| 02:45PM | Meridian Bioscience Successfully Completes Beta Trials for Two New illumigene® Tests Business Wire |
| 02:41PM | InPlay from Briefing.com Briefing.com |
| 12:19PM | Snag This Deal Even Lower Than EVP Baldini Did at Forbes |
| 12-Dec-12 01:52PM | Meridian Bioscience CEOs pay falls in 2012 at bizjournals.com |
| 10-Dec-12 01:20PM | Cash Dividend On The Way From Meridian Bioscience at Forbes |
| 06-Dec-12 12:13PM | Top Buys by Top Brass: EVP Baldini's $652.3K Bet on VIVO at Forbes |
| 10:06AM | Cincinnati Financial CEO Johnston: Tax change wont impact dividend at bizjournals.com |
| 05-Dec-12 10:36AM | LSI Industries accelerates dividend, declares extra payment at bizjournals.com |
| 04-Dec-12 01:19PM | Meridian Bioscience speeds dividend to avoid tax hike at bizjournals.com |
| 01:11PM | Meridian Bioscience moves up dividend payment AP |
| 01:04PM | MERIDIAN BIOSCIENCE INC Financials EDGAR Online Financials |
| 10:18AM | InPlay: Meridian Bioscience declares accelerated cash dividend of $0.19 per share payable on Dec 24, 2012 to shareholders of record on Dec 14, 2012 Briefing.com |
| 10:16AM | Meridian Bioscience announces accelerated payment date for quarterly dividend at theflyonthewall.com |
| 10:15AM | Meridian Bioscience, Inc. Declares Regular Quarterly Dividend and Accelerates Payment Date to December 24, 2012 Business Wire |
| 29-Nov-12 03:50PM | Microsoft Target Reduced and 4 Stock Analyses Making Rounds at Wall St. Cheat Sheet |
| 02:50PM | Microsoft Target Reduced and 4 Stock Analyses Making Rounds at Wall St. Cheat Sheet |
| 01:28PM | Microsoft Target Reduced and 4 Stock Analyses Making Rounds at Wall St. Cheat Sheet |
| 12:45PM | MERIDIAN BIOSCIENCE INC Files SEC form 10-K, Annual Report EDGAR Online |
| 10:57AM | Microsoft Target Reduced and 4 Stock Analyses Making Rounds at Wall St. Cheat Sheet |
| 07:15AM | Meridian Bioscience concerns reflected in guidance and estimates, says Cowen at theflyonthewall.com |
| 28-Nov-12 06:16PM | Nasdaq stocks posting largest percentage decreases AP -5.05% |
| 01:47PM | Nasdaq stocks posting largest percentage decreases AP |
| 01:01PM | United and More Big Movers in Healthcare on November 28, 2012 at Investopedia |
| 12:43PM | Midday Movers: AEO, ANN, KCG & More at CNBC |
| 07:00AM | SensiFAST Genotyping Kit Exceed the Limit Business Wire |
| 22-Nov-12 05:34AM | 5 Dividend Stocks Yielding Above 3% In Uptrend at Seeking Alpha |
| 20-Nov-12 11:37AM | Meridian Bioscience Breaks Below 200-Day Moving Average - Notable for VIVO at Forbes |
| 19-Nov-12 04:22PM | Game Changer in Hospital Labs? at Motley Fool |
| 13-Nov-12 10:31AM | Ex-Div Reminder for Meridian Bioscience at Forbes |
| 08:43AM | MERIDIAN BIOSCIENCE INC Files SEC form 8-K, Results of Operations and Financial Condition, Amendments to Articles of EDGAR Online |
| 10-Nov-12 09:29AM | New Star Analyst Rankings for Meridian Bioscience Inc. StarMine |
| 09-Nov-12 05:13PM | Meridian Bioscience Beats on Both Top and Bottom Lines at Motley Fool |
| 09:32AM | New Star Analyst Rankings for Meridian Bioscience Inc. StarMine |
| 08-Nov-12 02:51PM | Cincinnati Financial sees gains from keeping P&G shares at bizjournals.com |
| 01:18PM | Meridian earnings soar at bizjournals.com |
| 07:33AM | InPlay: Meridian Bioscience beats by $0.02, beats on revs; reaffirms FY13 EPS guidance, revs guidance Briefing.com |
| 07:30AM | Meridian Bioscience Reports Fourth Quarter and Full-Year 2012 Operating Results, Declares Regular Cash Dividend, and Reaffirms Fiscal 2013 Guidance Business Wire |
| 31-Oct-12 03:00PM | Market Movers: Meridan soars, AK Steel slumps at bizjournals.com |
| 19-Oct-12 04:27PM | VIVO Crosses Below Key Moving Average Level at Forbes |
| 15-Oct-12 02:14PM | 3 Companies To Consider In The Wake Of Yet Another Red Flag For Dendreon at Seeking Alpha |
|
|
| Meridian Bioscience, Inc., a life science company, develops, manufactures, sells, and distributes clinical diagnostic test kits primarily for gastrointestinal, viral, respiratory, and parasitic infectious diseases. The company’s diagnostic products principally include C. difficile for the detection of gastrointestinal diseases, such as antibiotic-associated diarrhea; Rotavirus and Adenovirus products for pediatric diarrhea detection; H. pylori for the detection of stomach ulcers; EHEC test for the detection of Enterohemorrhagic E. coli infection and Campy for the detection of Campylobacter jejuni; and Group A Strep and Group B Strep tests for the detection of streptococcus bacterial infections. Its diagnostic products are also used in the detection of viral diseases, such as mononucleosis, herpes simplex, chicken pox, and shingles; organ transplant infections; parasitic diseases, including giardiasis, cryptosporidiosis, and lyme; and respiratory diseases, such as pneumonia, valley fever, influenza, and respiratory syncytial virus. The company also offers transport media that store and preserve specimen samples from patient collection to laboratory testing; and bulk antigens, antibodies, PCR/qPCR reagents, nucleotides, competent cells, and bioresearch reagents used by researchers and other diagnostic companies. In addition, it engages in the contract development and manufacture of proteins and other biologicals under cGMP conditions for use by biopharmaceutical and biotechnology companies engaged in research for new drugs and vaccines; and sale and distribution of diagnostic test kits manufactured by third-party vendors. The company markets its products through direct sales force and independent distributors primarily to hospitals, reference laboratories, and research customers in the United States, Asia, Canada, South America, Australia, Europe, Africa, and the Middle East. Meridian Bioscience, Inc. was founded in 1976 and is headquartered in Cincinnati, Ohio. |
|
| Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
| KRAEUTLER JOHN A | Chief Executive Officer | May 01 | Buy | 19.63 | 5,000 | 98,167 | 225,718 | May 03 10:52 AM | | READY ROBERT J | Director | Mar 11 | Sale | 21.69 | 5,000 | 108,439 | 5,959 | Mar 12 02:07 PM | | MOTTO WILLIAM J | Executive Chairman | Mar 05 | Sale | 21.59 | 2,500 | 53,973 | 75,458 | Mar 06 02:28 PM | | LUEKE MELISSA | Exec VP, CFO | Dec 14 | Sale | 19.83 | 15,750 | 312,264 | 114,015 | Dec 17 11:45 AM | | LUEKE MELISSA | Exec VP, CFO | Dec 13 | Option Exercise | 0.00 | 21,000 | 0 | 129,765 | Dec 17 11:45 AM | | LUEKE MELISSA | Exec VP, CFO | Dec 13 | Sale | 19.88 | 5,250 | 104,385 | 114,015 | Dec 17 11:45 AM | | EBERLY RICHARD | EVP,Pres Meridian Life Science | Dec 11 | Option Exercise | 0.00 | 31,500 | 0 | 69,246 | Dec 13 03:30 PM | | EBERLY RICHARD | EVP,Pres Meridian Life Science | Dec 11 | Sale | 20.47 | 31,500 | 644,660 | 37,746 | Dec 13 03:30 PM | | MOTTO WILLIAM J | Executive Chairman | Dec 06 | Sale | 20.50 | 1,500 | 30,750 | 77,958 | Dec 07 10:21 AM | | MOTTO WILLIAM J | Executive Chairman | Dec 05 | Option Exercise | 0.00 | 15,750 | 0 | 65,750 | Dec 07 10:21 AM | | READY ROBERT J | Director | Dec 05 | Sale | 20.29 | 6,000 | 121,750 | 10,959 | Dec 07 10:11 AM | | MOTTO WILLIAM J | Executive Chairman | Dec 05 | Sale | 20.34 | 15,750 | 320,308 | 50,000 | Dec 07 10:21 AM | | BALDINI LAWRENCE | Exec VP, Operations & IS | Dec 04 | Buy | 20.07 | 32,500 | 652,295 | 70,000 | Dec 05 05:06 PM | | BALDINI LAWRENCE | Exec VP, Operations & IS | Dec 03 | Sale | 20.00 | 32,500 | 650,000 | 37,500 | Dec 05 05:06 PM | | ROLIH SUSAN | Sr. VP, Reg Affairs and QA | Nov 13 | Option Exercise | 2.80 | 22,500 | 63,000 | 91,250 | Nov 15 01:32 PM | | READY ROBERT J | Director | Nov 13 | Sale | 19.46 | 1,800 | 35,028 | 16,959 | Nov 15 01:35 PM | | MOTTO WILLIAM J | Executive Chairman | Sep 10 | Option Exercise | 2.80 | 7,988 | 22,366 | 47,988 | Sep 11 03:40 PM | | MOTTO WILLIAM J | Executive Chairman | Sep 10 | Sale | 18.34 | 7,988 | 146,462 | 40,000 | Sep 11 03:40 PM |
|
|
|
|
|
|
